Although silver sulfadiazine (AgSD) has received wide-spread acceptance as a topical agent to control bacterial infection, especially in burn wounds (2, 6-9, 13-15, 19, 20) , and is now approved by the Food and Drug Administration, its mechanism of action is uncertain.
This compound was prepared to combine the oligodynamic action of silver with the antibacterial effect of sulfadiazine (7) . Subsequent studies (9) showed that the sulfonamide antagonist para-aminobenzoic acid (PAB) did not nullify silver sulfadiazine inhibition, and that the silver moiety combined in vitro with both DNA and bacteria. The sedimentation coefficient of DNA isolated from AgSD-inhibited bacteria was found to be higher than that of normal DNA (22) . Subsequently, Carr and Rosenkranz (4) reported that AgSD became bound to the cell membrane and suggested that the resulting membrane damage 'caused the bactericidal action observed. The failure of PAB to block growth inhibition and the relatively low concentration of AgSD required made the role of the sulfadiazine uncertain. This was studied by experiments with "0AgSD and Ag35SD which showed that the AgSD dissociated, that Ag alone became bound to various components within the cell and that the inhibition of bacterial growth was related quantitatively to the binding of Ag to microbial DNA (16) .
This communication indicates the probable roles of silver and sulfadiazine and compares the reactions of AgSD, less effective silver sulfonamides and other silver salts with sodium chloride, DNA, human serum, and broth. The synergism of AgSD and SD is also shown. The observations may account for the unique efficacy of topical AgSD in preventing and treating infections and may help elucidate its mechanism of action in burns and infected wounds.
MATERIALS AND METHODS
Silver sulfadiazine was prepared as described previously (7).
Radioactive silver salts. The radioactive silver salts were prepared by reacting the sodium salts with "°AgNO, obtained from the International Chemical and Nuclear Corp. The silver salts thus prepared had a specific activity of about 1.0 Group of Iowa State University as Na"SD. The Ag35SD prepared from it had a specific activity of 1.0 mCi/mmol; the Na3"SD was also used as such in some of the experiments after dilution to the same specific activity. Bacterial strains. The Pseudomonas aeruginosa strain used in most of our experiments was obtained originally from Donald P. Dressler with the designation WHTG no. 2. This is highly virulent to both rats and mice and was used in our previous studies (9, 11, 16 Table 6 , ref.
8).
Inasmuch as the solubility of SD in water is only 0.5 gmol/ml, these considerably higher concentrations needed for bacteriostasis were attained by virtue of the fact that the pKa of sulfadiazine is 6.1, and at pH 7.0, most of the drug is in the form of NaSD (10). Significantly, the available H+ has been exchanged for Ag in AgSD and this solubility transformation cannot occur (except with decomposition) at extremely low or high pH.
Studies indicating the dissociation of AgSD prior to binding with DNA. The dissociation of AgSD has been further confirmed by studying the binding of Ag and SD to DNA by three different methods.
(i) Equilibrium dialysis. The binding to DNA of radioactive sulfadiazine from Ag35SD and Na 3SD and of radioactive silver from "0AgSD was studied by using an equilibrium dialysis technique. The results depicted in Table 2 show that no SD became bound to DNA either from Ag35SD or Na"SD; in sharp contrast, almost 25% of I°A g from I 1°AgSD became bound to the DNA.
(ii) Separation in Sephadex column. The elution pattern of Ag83SD-DNA complex is shown in Fig. 1 . The DNA was eluted in tubes 2 to 5 and carried no radioactivity from 85SD; the SD was eluted in tubes 6 to 11, and these contained all the radioactivity.
The elution patterns of 110Ag-DNA complexes from I"°AgSD and I10AgNO8 are shown in against 0.005 M NaNO,. Sulfadiazine absorbs strongly at X260 nm, and therefore each supernatant was analyzed for free, unreacted sulfadiazine. The supernatants were passed through Sephadex columns, and the eluates containing the free sulfadiazine were analyzed by the Bratton-Marshall colorimetric method (1). The OD260 measured for the DNA-AgSD mixtures was then corrected by subtracting the OD260 calculated for free sulfadiazine based on the colorimetric analysis. When AgNO3 was used, this correction was unnecessary.
As shown in Table 3 , the UV absorption of the Ag-DNA complex formed from AgSD was similar to that formed from AgNO, at the lower Ag/DNA-P ratios. The UV absorption of the DNA was not increased by either silver compound until the Ag/DNA-P ratio in the reaction mixture was about 0. 25 aThe binding ratios were estimated from the II0Ag taken up by the DNA.
'Free SD determined in the supernatant as described in Results. from AgNO, attained consistently higher Ag/ DNA ratios than those from AgSD, doubtless due to the greater solubility of AgNO,.
Thus, all three experimental methods indicated that AgSD dissociates upon combining with DNA, and that the SD moiety does not combine.
Reactions of silver salts with sodium chloride, nutrient broth, human serum, DNA, and bacteria. These reactions were studied to visualize the clinical experience in complex wound exudates.
Silver sulfadiazine and other silver salts were incubated with 0.01 M NaCl, nutrient broth, human serum, DNA, and bacterial suspensions, and at intervals the cations and anions released into the supernatant were measured. The percentage of silver salts unreacted after incubation with serum for various time intervals is shown in Fig. 3 . The reaction rates of these silver salts in the presence of the other test substances were similar to the patterns depicted in serum and hence are not shown here. The silver salts of sulfanilamide, uracil, and nitrate reacted almost completely within 15 min. Ag sulfacytosine, Ag sulfathiazole, and Ag sulfamerazine reacted very slowly, but silver sulfadiazine reacted at a moderate rate which continued so that 20% still remained unreacted after 40 h.
Binding of silver by growing cultures of Pseudomonas containing the supernatant and sediment fractions of serum reacted with silver salts. To simulate further the conditions existing in wound exudates, silver sulfadiazine and other silver salts were incubated with normal human serum and were subsequently exposed to bacteria. The serum-silver salt mixtures were centrifuged after incubation, and the supernatants ( collected. Portions (corresponding to 0.1 umol of silver based on actual counts and specific activity of "0Ag used) were taken from both these supernatants and sediments to determine the binding of silver by bacteria. For this purpose each fraction received 5 ml of early log phase cultures (0.4 to 0.5 OD) and all were incubated for 3 h. The tubes containing the silver salt residues were then given a preliminary centrifugation at 2,000 rpm for 5 min, after which the residues of unreacted silver salts were discarded, and the supernatants containing the bacteria were pipetted off. These supernatants were again centrifuged, at 8,000 rpm for 10 min, and the silver uptake was measured on the sedimented bacterial cell mass by counting the associated radioactivity. VOL. 5, 1974 585 The bacterial binding of silver from the supernatants and sediments of the various siIver salts reacted with serum are shown in Table  4 . The bacteria bound similar amounts of silver -from the supernatant fractions (15 to 18%) of all the silver salts. The bacterial binding from the sediments was higher; the maxima (74 and 83%, respectively) were attained with silver nitrate and silver sulfadiazine.
Synergism of silver sulfadiazine and sodium sulfadiazine against Pseudomonas aeruginosa. The combinations of AgSD and SD used are shown in 14.5 Silver sulfamerazine 58 14.8 Silver sulfathiazole 54 18.5 Silver nitrateb 74 16.8 Silver chloride" 76 15.0 Silver sulfadiazine 83 15.5 aThe percentage of silver bound to the bacteria was calculated using the initial "0Ag counts in each residue and each supernatant as 100%.°H andled in dark to minimize rapid decomposition and darkening in light. h. tuted; this suggests that the synergism observed is specific for sulfadiazine.
DISCUSSION
The dissociation of AgSD during inhibition of bacterial growth has been described (16) but to determine the role of each constituent, confirmation by other experimental methods is essential. It is now clear that no significant amount of SD entered the bacterial cells (either Pseudomonas or Staphylococcus) even during inhibition by the much higher concentrations of NaSD. It is thus unlikely that SD entry in the cell occurs at the lower concentrations used for AgSD inhibition.
It was further found by three different methods that silver-DNA complexes formed from AgSD and DNA in vitro contained no SD. ANTIMICROB Thus, although SD does not appear to function chemically in the bactericidal action of AgSD, in infected burns in animals this compound proved superior to the many other silver compounds prepared and tested. All the silver compounds listed in Table 6 showed strong antibacterial action in vitro, but proved ineffectual in vivo.
It seemed plausible that this efficacy of the SD combination with Ag might be due to a difference in dissociation and/or reaction rate under physiologic conditions. To explore this possibility, the reactions of various silver salts with sodium chloride, nutrient broth, DNA, bacteria, and human serum were studied. Most of the compounds either dissociated completely with rapid removal of all silver, or else dissociated only slightly without appreciable release of silver over a period of time. AgSD, on the contrary, showed a moderate initial dissociation, with continual release of silver over the time observed. The ionization constants of the sulfonamides (10) , and possibly of the other compounds also, would appear to contribute importantly to the differences in the antibacterial activity of their silver salts. To estimate the obtainable silver ions on the wound surface when these different silver salts were used, the bacterial binding of silver from the supernatant and sediments of human serum reacted with these compounds was measured. Considerable amounts of AgSC, AgSM, and AgST remained unreacted in the sediment; the uptake from these compounds was much less, presumably because of their slow dissociation rates, hence the non-availability of silver ions. The maximum silver binding was obtained from AgNO, and AgSD. With AgNO,, the sediment may constitute precipitated silver proteinate and silver chloride which are capable of releasing free silver ions and producing the characteristic black staining.
The similarity of binding from the supernatants of all these compounds suggests that any large amounts of silver released were precipitated as silver proteinate and AgCl and remained sedimented. In the case of AgSD, the sediment consisted mostly of unreacted silver sulfadiazine. Thus, silver sulfadiazine functioned as a reservoir of obtainable silver in the wound. This slow liberation of silver ions does not cause the rapid and extensive depletion of chloride ion experienced with continuous silver nitrate solution soaks, and hence systemic electrolyte withdrawal is avoided (2, 8) . Since only a small part of the silver in AgSD reacted with the chloride, protein and other constituents of body fluids, enough was available to be acquired by microorganisms, so that many were killed and their growth inhibited. The correspondingly low level of sulfadiazine proved innocuous and practically no silver was absorbed. (2, 9 
